Latest news
Sino Bio's benmelstobart-anlotinib regimen adds new China indication in first-line squamous NSCLC - AllSciAllSci · Fri, 07 Aug 2026 16:21:02 GMTMediar partners with Ono Pharma on fibro-inflammatory discovery - AllSciAllSci · Thu, 06 Aug 2026 16:25:44 GMTBezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSciAllSci · Thu, 06 Aug 2026 16:12:09 GMTLuye clears US bridging milestone for first dual-mechanism TD therapy - AllSciAllSci · Thu, 06 Aug 2026 13:51:07 GMTSummit expands ivonescimab's challenge to Keytruda into bladder cancer - AllSciAllSci · Thu, 06 Aug 2026 09:59:29 GMTForlong advances IL-15 superagonist into Australian Phase I trial with subcutaneous dosing - AllSciAllSci · Wed, 05 Aug 2026 10:31:21 GMTModerna launches first clinical trial of mRNA vaccine against Bundibugyo ebolavirus strain - AllSciAllSci · Wed, 05 Aug 2026 10:23:59 GMTViiV's two-drug Dovato matches three-drug Biktarvy in first head-to-head HIV trial - AllSciAllSci · Tue, 28 Jul 2026 08:24:47 GMT